Qualcomm said its new architecture supports advanced perception and motion planning with end-to-end AI models.

Vicarious Surgical (NYSE:RBOT) announced today that it successfully completed an in-vivo porcine lab as it advances its ...

Seeking Alpha's roundup of statements, announcements, and remarks that could impact the technology sector. Read more here.

NVIDIA and Lilly to invest $1B in AI lab to accelerate drug discovery with BioNeMo, robotics, and large-scale biomedical ...

Lilly Nvidia launch drug AI lab in the Bay Area with $1B investment to speed drug discovery using advanced AI and robotics.

Companies to Jointly Invest up to $1 Billion Over Five Years in Infrastructure and Research NVIDIA and Lilly NVIDIA and Eli ...

Eli Lilly (NYSE:LLY) shares climbed nearly 2% on Monday after the drugmaker announced a major artificial intelligence partnership with Nvidia (NASDAQ:NVDA). The two companies said they plan to invest ...

The December in-vivo lab builds on Vicarious Surgical's disciplined, specification-driven development approach and reflects the company's focus on minimizing technical risk through iterative testing, ...

Nvidia and Eli Lilly are investing $1 billion over five years to establish a joint research lab in the San Francisco Bay area.

South San Francisco is poised to become an even hotter address for biotech and chip companies. Nvidia and Eli Lilly said ...

So what will be the big tech stories of 2026? There are the usual suspects, to be sure, with upcoming devices from Apple, ...

In a groundbreaking announcement, tech giant NVIDIA and pharmaceutical leader Eli Lilly and Co. are joining forces to establish an artificial intelligence lab aimed at transforming drug discovery.